Variant TLR4 nucleic acid and uses thereof
The invention provides methods to identify polymorphisms at the human TLR4 locus, as well as methods to identify individuals at risk of indications that increase their morbidity and mortality.
1. A method of identifying a human at risk of, or having, an indication associated with altered innate immunity, comprising:
a) contacting an amount of a nucleic acid sample obtained from a human physiological sample with an amount of at least one Toll-like receptor-4 (TLR4)-specific oligonucleotide under conditions effective to amplify TLR4 DNA having SEQ ID NO:62, the complement thereof, or a portion thereof, so as to yield amplified TLR4 DNA, that includes nucleic acids that encode residue 299 or 399 of a TLR4 polypeptide wherein the at least one TLR4-specific oligonucleotide comprises at least two nucleotide substitutions which result in a restriction site that is indicative of a polymorphism in a human TLR4 gene, which polymorphism results in a TLR4 gene that encodes a TLR4 polypeptide with an amino acid substitution at residue 299 or 399; and
b) detecting or determining whether the amplified TLR4 DNA comprises nucleic acid encoding a TLR4 polypeptide having an amino acid substitution at residue 299 or 399, thereby identifying whether the human is at risk of or has an indication associated with innate immunity.
2. The method of claim 1 wherein the amplified TLR4 DNA has a codon for a naturally occurring amino acid residue other than aspartic acid at position 299 in TLR4 or a codon for a naturally occurring amino acid residue other than threonine at position 399 in TLR4.
3. The method of claim 1 wherein the oligonucleotide comprises SEQ ID NO:66 or SEQ ID NO:67.
4. The method of claim 1 wherein the oligonucleotide comprises SEQ ID NO:68 or SEQ ID NO:69.
5. The method of claim 1 wherein the amplified DNA comprises GGT at the codon for residue 299.
6. The method of claim 1 wherein the amplified DNA comprises ATC at the codon for residue 399.
7. A method to detect a polymorphism in a human Toll-like receptor-4 (TLR4) gene, comprising: detecting or determining whether amplified TLR4 DNA obtained from a human nucleic acid sample comprises a nucleic acid encoding a TLR4 polypeptide having a codon for a naturally occurring amino acid residue other than aspartic acid at position 299 in TLR4 or a codon for a naturally occurring amino acid residue other than threonine at position 399.
8. The method of claim 1 or 7 wherein the nucleic acid sample comprises genomic DNA.
9. The method of claim 1 or 7 wherein the nucleic acid sample is cDNA.
10. The method of claim 1 or 7 wherein the substitution at residue 299 is glycine for aspartic acid or the substitution at residue 399 is isoleucine for threonine.
11. The method of claim 7 wherein the TLR4-specific oligonucleotide is SEQ ID NO:19 or SEQ ID NO:43.
12. The method of claim 7 wherein the TLR4-specific oligonucleotide is SEQ ID NO:22 or SEQ ID NO:46.
13. The method of claim 7 wherein at least two TLR4 specific oligonucleotides are contacted with the sample.
14. The method of claim 13 wherein the two TLR4 specific oligonucleotides are SEQ ID NO:19 and SEQ ID NO:22.
15. The method of claim 13 wherein the two TLR4 specific oligonucleotides are SEQ ID NO:43 and SEQ ID NO:46.
16. The method of claim 7 wherein the polymorphism is detected or determined with at least one TLR4-specific oligonucleotide comprises at least two nucleotide substitutions which result in a restriction site that is indicative of the polymorphism, which polymorphism results in a TLR4 gene that encodes a TLR4 polypeptide with an amino acid substitution at residue 299 or 399.